LOGO
LOGO

Intraday Alerts

Cumberland Pharmaceuticals Stock Soars 44% Over $100 Mln Deal To Sell Branded Drugs To Apotex

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Shares of Cumberland Pharmaceuticals Inc. (CPIX) are rising about 44 percent during Thursday morning trading following the company's agreement with an affiliate of Apotex to integrate their branded U.S. businesses.

The company's shares are currently trading at $4.4001 on the Nasdaq, up 44.29 percent. The stock opened at $5.75 and has climbed as high as $6.0399 so far in today's session. Over the past year, it has traded in a range of $1.8500 to $6.2700.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19